Eric L. Abhold, University of California, San Diego, CA. Abstract #4904. Epidermal Growth Factor Receptor Promotes Acquitistion of Stem Cell Properties in Cancer Benign Tumor Cell Lines.
Stephen A. Allsop, North Carolina Central University, Durham, NC. Abstract #4347. Pim kinases are potential molecular targets in K-Ras mediated transformation of pancreatic cancer. (Not first author)
Danielle S. Daniels, University of Alabama, Birmingham, AL. Abstract #1175. Identification of a cryptic sequence required for BRMS1 metastasis suppression. (Not first author)
Caroline M. Garber, Cleveland Clinic Foundation, Cleveland, OH. Abstract #4531. Antitumor effects of N-heterocylic carbene silver acetate complexes compared to cisplatin, carboplatin and oxaliplatin.
Kelly A. Gewain, University of North Carolina, Chapel Hill, NC. Abstract #3643. RhoGEF inhibitors: Identifying GTPase selectivity of potential molecularly targeted therapeutics.
Joanna Maya, Birmingham-Southern College, Birmingham, AL. Abstract #4384. Regulation of expression and role of the Pigment Epithelium Derived Factor in Ras-mediated oncogenesis.
Tyler E. Miller, The Ohio State University, Columbus, OH. Abstract #2539. Regulation of miRNA-221 and miRNA-222 in tamoxifen resistant breast cancer.
Rangarajan D. Nadadur, Massachusetts Institute of Technology, Cambridge, MA. Abstract #3840. Expression of the metastatic prostate cancer biomarker miR-141 in prostate biopsy tissues.
Bianca S. Oliver, North Carolina Agricultural & Technical State University. Abstract #3270. DMBA-mediated survival signal: Via NF-KappaB regulation in non-transformed human mammary epithelial cells.
Wenhui Zhou, University of California, Davis, CA. Abstract #1122. The role of ADAM8 in the regulation of pathological neovascularization and in the ectodomain shedding of receptors involved in this process.